TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/21/20 19:03 | 8/19/20 | NBRV | Nabriva Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Crotty Robert | PA | O | GC,Corp | M.d | 0 | 0.00 | 0 | 11 | 6 | 205 | D | ||||||||||||||
8/26/19 21:35 | 8/21/19 | NBRV | Nabriva Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Crotty Robert | PA | O | GC,Corp | S.a | -8 | 2.08 | 0 | -4 | -14 | 23 | D | ||||||||||||||
8/21/19 21:22 | 8/19/19 | NBRV | Nabriva Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Crotty Robert | PA | O | GC,Corp | M.d | 0 | 0.00 | 0 | 11 | 94 | 23 | D | ||||||||||||||
5/23/18 12:29 | 5/23/18 | NBRV | Nabriva Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Crotty Robert | PA | O | GC,Secre | P | 45 | 4.48 | 0 | 10 | New | 10 | D | ||||||||||||||
2/18/15 20:23 | 2/17/15 | DNDNQ | Dendreon Corp | DE | Health | Drug | Pharmaceutical Preparations | Crotty Robert | WA | O | EVP,GC | S | -2 | 0.0811 | 0 | -22 | -18 | 98 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |